Attached files

file filename
10-K - FORM 10K - ABEONA THERAPEUTICS INC.a10k_123109.htm
EX-23.1 - AUDITORS CONSENT - ABEONA THERAPEUTICS INC.ex_23-1.htm
EX-21 - SUBSIDIARIES - ABEONA THERAPEUTICS INC.ex_21.htm
EX-31.2 - CFO CERTIFICATION - ABEONA THERAPEUTICS INC.ex_31-2.htm
EX-10.9 - RIGHTS AGREEMENT AMENDED - ABEONA THERAPEUTICS INC.ex_10-9.htm
EX-31.1 - CEO CERTIFICATION - ABEONA THERAPEUTICS INC.ex_31-1.htm

EXHIBIT 32
 


 

 
CERTIFICATION PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

This certification set forth below is hereby made solely for the purposes of satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 and may not be relied upon or used for any other purposes.

A signed original of this written statement required by Section 906 has been provided to Access Pharmaceuticals, Inc. and will be retained by Access Pharmaceuticals, Inc. and furnished to the SEC or its staff upon its request.

Pursuant to Section 906 of the Public Company Accounting Reform and Investor Act of 2002 (18 U.S.C. 1350, as adopted, the “Sarbanes-Oxley Act”), Jeffrey B. Davis, Chief Executive Officer of Access Pharmaceuticals, Inc. (the "Company"), and Stephen B. Thompson, Vice President and Chief Financial Officer of the Company, each hereby certifies that to his knowledge the Annual Report on Form 10-K for the period ended December 31, 2009 of the Company filed with the Securities and Exchange Commission on the date hereof (the "Report") fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period specified.

Signed at the City of  Dallas, in the State of Texas, this 22 nd day of March, 2010.


                                                                              
Jeffrey B. Davis                                                                        Stephen B. Thompson
Chief Executive Officer                                                           Chief Financial Officer
Principal Executive Officer                                                     Principal Financial and Accounting Officer